As summer officially begins, please put on a wide-brimmed hat and stay in the shade, measures that can help prevent melanoma.
2023
Pointers With Portela: Surviving Melanoma
Dustin Portela, DO, a board-certified dermatologist and dermatologic surgeon at Treasure Valley Dermatology in Boise, Idaho, interviews a patient who has been battling metastatic stage IV melanoma for many years. In his most recent Health IQ podcast, Portela speaks with Katie, who used her experience of her melanoma diagnosis to become an advocate for those living with melanoma.
Phase 3 Trial of Lifileucel/Pembrolizumab in Frontline Advanced Melanoma Begins
The phase 3 TILVANCE-301 trial (NCT05727904) evaluating the tumor infiltrating lymphocyte (TIL) therapy, lifileucel (LN-144) in combination with pembrolizumab (Keytruda) vs pembrolizumab alone has randomized its first patient with frontline advanced, unresectable, or metastatic melanoma.
World-first melanoma study to boost early detection
A world-first study, for which The Alfred is the Victorian lead, is using 3D skin imaging technology and artificial intelligence to significantly improve the early detection of melanoma for all Australians.